Bank Of New York Mellon Corp Mustang Bio, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.32 - $8.27 $23,692 - $612,310	74,040 New	74,040 $28,000
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $106,105 - $206,723	-182,941 Reduced 71.1%	74,365 $44,000
Q1 2022 May 11, 2022	SELL	$0.73 - $1.81 $1,262 - $3,131	-1,730 Reduced 0.67%	257,306 $260,000
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $10,205 - $16,230	6,148 Added 2.43%	259,036 $430,000
Q3 2021 Nov 12, 2021	BUY	$2.58 - $3.36 $49,056 - $63,887	19,014 Added 8.13%	252,888 $680,000
Q2 2021 Aug 11, 2021	BUY	$2.7 - $3.81 $140,167 - $197,792	51,914 Added 28.53%	233,874 $776,000
Q1 2021 May 13, 2021	BUY	$3.02 - $5.16 $504 - $861	167 Added 0.09%	181,960 $604,000
Q4 2020 Feb 09, 2021	BUY	$2.66 - $4.18 $171,676 - $269,777	64,540 Added 55.04%	181,793 $688,000
Q3 2020 Nov 12, 2020	SELL	$3.01 - $3.88 $8,307 - $10,708	-2,760 Reduced 2.3%	117,253 $369,000
Q2 2020 Aug 12, 2020	SELL	$2.33 - $4.6 $18,595 - $36,712	-7,981 Reduced 6.24%	120,013 $381,000
Q1 2020 May 06, 2020	SELL	$1.91 - $4.52 $1,453 - $3,439	-761 Reduced 0.59%	127,994 $343,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.08 $11,629 - $18,462	4,525 Added 3.64%	128,755 $525,000
Q3 2019 Nov 07, 2019	BUY	$2.74 - $4.65 $77,043 - $130,748	28,118 Added 29.26%	124,230 $404,000
Q2 2019 Aug 12, 2019	BUY	$2.66 - $6.28 $109,538 - $258,610	41,180 Added 74.97%	96,112 $354,000
Q1 2019 May 14, 2019	SELL	$2.95 - $5.61 $2,171 - $4,128	-736 Reduced 1.32%	54,932 $188,000
Q4 2018 Feb 11, 2019	BUY	$2.3 - $5.78 $27,855 - $70,001	12,111 Added 27.8%	55,668 $163,000
Q2 2018 Aug 06, 2018	BUY	$6.68 - $11.0 $208,395 - $343,167	31,197 Added 252.4%	43,557 $300,000
Q1 2018 May 15, 2018	BUY	$10.14 - $12.38 $125,330 - $153,016	12,360 New	12,360 $136,000

Others Institutions Holding MBIO

# of Institutions

Shares Held

415K

Call Options Held

Put Options Held

View Full List

About MUSTANG BIO, INC.

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

More about MBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account